Liposorber

05/10/2026

From the Liposorber team, Happy Mother’s Day to every kind of mom and mother figure out there - those who love fiercely, give endlessly, and hold everything together in ways that often go unseen💗💐

05/08/2026

What an incredible two days in New York City with our latest group of Liposorber nurses 💙

From hands-on education and clinical discussions to amazing meals, a memorable NYC food tour, and heartfelt conversations with a brave HoFH patient and her family - this seminar was a reminder of the impact apheresis nurses make every single day.

Thank you to each nurse who attended for your engagement, thoughtful questions, and dedication to learning. Your compassion and commitment to patient care are what make programs like this so meaningful. We’re grateful to be part of your Liposorber journey and look forward to supporting you as you bring this therapy to your patients.

And a special thank you to Jade, Scott, and Aubree for sharing your family’s HoFH journey with us ♥️

Your story was both powerful and inspiring, and served as an important reminder of the real lives impacted by these treatments. Thank you for allowing us to learn from your experiences and for leaving such a lasting impression on all of us.

PatientCare MedicalTraining

05/04/2026

Today is HoFH Awareness Day, held annually on May 4th to shine a spotlight Homozygous Familial Hypercholesterolemia (HoFH), a rare, severe genetic condition causing extremely high LDL cholesterol from birth.

This day focuses on raising awareness, supporting early diagnosis, and sharing resources to help individuals and families better understand and manage HoFH.

To learn more, visit: familyheart.org/event/hofh-awareness-day

For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info

05/01/2026

Bringing the team together 🤝✨

A couple weeks ago, we kicked off our fiscal year in Stamford, CT with 2 days of collaboration, team building, and a lot of laughs. It’s not often we all get to be in the same room, so moments like these remind us just how strong our team is across every corner of the country.

Grateful for the connections, the energy, and the shared vision as we head into FY26 🙌🏼💼🚀

04/27/2026

There’s nothing better than getting to connect face-to-face with the incredible apheresis nurses who use Liposorber — the ones we know, trust, and truly consider part of our extended team. These moments of catching up, sharing stories, and learning from each other are what it’s all about.

This conference brings together the best in apheresis medicine, from groundbreaking advancements to meaningful conversations with physicians, scientists, and care teams from around the world. We’re proud to be part of a community so dedicated to improving patient outcomes.

Already looking forward to the next one. 💙

04/27/2026

LIPOSORBER® is an advanced, FDA-approved extracorporeal therapy designed to directly remove harmful LDL-C and Lp(a) from the blood. With over 600,000 treatments performed worldwide, it is a trusted clinical alternative for those seeking life-changing results.

For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info

Discover LIPOSORBER, the FDA-approved clinical therapy and proven alternative for lowering high cholesterol levels (LDL-C, Lp(a)) when maximum drug therapies don't work.

04/25/2026

Happy National DNA Day! 🧬 Today we recognize the incredible advancements in genetics that help us understand conditions like Familial Hypercholesterolemia (FH).

For many, high cholesterol isn't just about lifestyle—it’s in their DNA. When diet and maximum drug therapy aren't enough to reach healthy levels, LIPOSORBER® is here to help physically remove LDL cholesterol from the blood. Knowledge is power, know your family history!

For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info

04/23/2026

We’ve created video resources to walk you through the LIPOSORBER® therapy experience step-by-step. Whether you're an adult patient or a caregiver for a pediatric patient, our "What to Expect" guides are here to answer your questions and help you feel prepared for your first session. Visit our website to watch!

For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info

04/21/2026

Uncontrolled high cholesterol and elevated Lp(a) significantly increase the risk of heart attack and stroke. For high-risk patients who have exhausted maximum drug therapies due to lack of efficacy or intolerance, LIPOSORBER® has been proven to reduce coronary events by up to 72%.* Don't let genetics dictate your future—explore your options today.

*Reference: Mabuchi, H et al. “Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia.” Hokuriku-FH-LDL-Apheresis Study Group. The American journal of cardiology vol. 82,12 (1998): 1489-95. doi:10.1016/s0002-9149(98)00692-4.

For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info

04/19/2026

This month, we shine our Patient Spotlight on Kate, an FH patient who has been able to pursue her PhD, thanks to treatment with LIPOSORBER:

"Several years into working towards my PhD in Microbiology and Immunology at the Medical College of Wisconsin, my health took a sudden and devastating turn. For years I searched desperately for an explanation while my health continued to decline, eventually leaving me partially paralyzed.

Losing my health was crushing – but losing my career in the sciences was a loss to the core of who I was. Research wasn’t just my job; it was my greatest passion, my proudest achievement, the thing that ignited my brain… and when I had to step away, it felt like my future had been canceled.

In 2023, after years of uncertainty, I was diagnosed with a chronic autoimmune neurodegenerative disease followed by familial hypercholesterolemia (FH). Then the real work began. With a team of medical professionals, I began a comprehensive treatment plan including lipoprotein apheresis.

Trying to capture how lipoprotein apheresis has impacted me personally is no trivial task!
• It allows me to avoid medications that come with nasty side-effects and drug interactions.
• It reduces inflammation, which boosts my day-to-day energy levels.
• It gives me reassurance - a sense that I am actively protecting my long-term cardiovascular health and reducing my risk of heart attack or stroke.

Most remarkably: consider my career uncanceled. Indeed, I am back in pursuit of my PhD at the Medical College of Wisconsin.

From a patient’s perspective, my advice is lipoprotein apheresis is a potential tool that may aid you in reclaiming the life you want to live. Take the time to explore it as an option. You are worth it!"

For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info

04/16/2026

Driven by a passion for advancing cardiovascular prevention, Dr. Maya Safarova brings cutting‑edge science directly to patient care at Froedtert Hospital & the Medical College of Wisconsin (through Versiti). Her clinical expertise spans women’s heart health, heritable lipid disorders, aortopathies, and echocardiography. As a physician‑scientist, her research sits at the intersection of genetics, informatics, and imaging—focusing on vascular aging through innovative epigenetic and multi‑omics approaches. Her mission: build healthier lives free of atherosclerotic cardiovascular disease.

Dr. Safarova is a strong advocate for personalized prevention, recognizing that every patient’s risk is shaped by their unique genetics, gender, race, ethnicity, and likelihood of disease progression. She believes that meaningful prevention requires moving beyond traditional markers and providing truly individualized care.

A key part of her practice includes supporting patients with elevated lipoprotein(a) [Lp(a)], a significant but often overlooked driver of residual cardiovascular risk. Dr. Safarova incorporates Lipoprotein Apheresis therapy for patients who maintain optimal LDL‑C levels yet continue to face heightened risk for major adverse cardiovascular events due to Lp(a) levels above 60 mg/dL (130 nmol/L). She views apheresis as an important therapeutic option for these high‑risk individuals—one that aligns with her commitment to precision medicine and proactive, data‑driven care.

For LIPOSORBER Indications for Use and other safety information, please visit: liposorber.com/liposorber-safety-info